PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, presenting promising developments across many clinical and industrial purposes. With its structural similarity to Normally derived Recombinant human serum albumin human serum albumin, OsrHSA gives a safer, more dependable alternate